Beranda › Obesitas › Washington › Bellevue
Uji klinis Obesitas di Bellevue, WA
4 studi untuk Obesitas mencari peserta di lokasi sekitar Bellevue (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Menerima pesertaFase 2
- Northwest Clinical Research Center, Bellevue
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Menerima pesertaFase 4
- Bellevue Dermatology Clinic, Bellevue
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Menerima pesertaFase 3
- Northwest Clinical Research Center, Bellevue
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Menerima pesertaFase 3
- Northwest Clinical Research Center, Bellevue
Uji klinis Obesitas di kota lain
- Houston, TX43 studi
- Chicago, IL41 studi
- New York City, NY40 studi
- San Antonio, TX40 studi
- Washington, DC33 studi
- Orlando, FL31 studi
- Dallas, TX30 studi
- Boston, MA28 studi
- Las Vegas, NV27 studi
- Miami, FL27 studi
- Baltimore, MD25 studi
- Jacksonville, FL25 studi
Studi lain di Bellevue
- Gangguan Depresi Mayor10 studi
- Depresi6 studi
- Kolitis Ulseratif6 studi
- Skizofrenia5 studi
- Penyakit Alzheimer5 studi
- Gangguan Bipolar4 studi
- Osteoartritis Lutut4 studi
- Penyakit Crohn4 studi
- Penyakit Hati Steatotik3 studi
- Gangguan Kecemasan Umum3 studi
- Gangguan Suasana Hati3 studi
- Gangguan Psikotik3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.